Dr. Paul Parren - Gilde Healthcare

team
Venture&Growth

All team members
Dr. Paul Parren
Operational Partner
The Netherlands

Dr. Paul Parren

Operational Partner

Paul Parren is an internationally recognized antibody drug innovator and developer. Paul was Head of Preclinical Development and Research at Genmab (2002-2017), translating antibody biology successfully into immunotherapies from discovery to the clinic, including approved therapeutic antibodies ofatumumab and daratumumab, as well as establishing validated antibody platform technologies. He is a Professor of Molecular Immunology at the Leiden University Medical Center in Leiden, the Netherlands, board member of The Antibody Society and was an Associate Professor at The Scripps Research Institute in La Jolla, California. He holds a PhD in Molecular Immunology from the University of Amsterdam.

Paul assists Gilde in the evaluation of investment opportunities and is also acting as Executive Vice President and Head of Research & Development for Gilde’s portfolio company Lava Therapeutics.

Edward Hanlon

Senior Associate Healthtech
Venture&Growth
Edward Hanlon joined Gilde Healthcare in 2020 in the Cambridge office and focuses on Healthtech. Prior to joining Gilde, Edward worked in advisory for Health Advances, a consulting firm operating across healthcare sectors in medical...

Susana Amorim

Senior Associate Healthtech
Venture&Growth
Susana Amorim joined Gilde in 2021 and focuses on the Healthtech sector. She is involved in deal sourcing, investment diligence, and portfolio management. Prior to joining Gilde, Susana was a Biodesign Innovation fellow at Stanford University, a...

Professor Dr. Rene Bernards

Operational Partner
Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute...